National and Kapodistrian University of Athens
Η επίδραση της προδιαστολής πριν τη διακαθετηριακή εμφύτευση βιοπροσθετικής αυτοεκπτυσσόμενης αορτικής βαλβίδας στη βραχυπρόθεσμη και μακροπρόθεσμη έκβαση των ασθενών που υποβάλλονται σε αυτήν
Abstract
dc:descriptionBalloon aortic valvuloplasty (BAV) has been used prior to valve implantation of a self- expandable valve as part of the transcatheter aortic valve implantation (TAVI) procedure. We aimed to evaluate the impact of BAV prior to TAVI. We studied 262 consecutive patients who were treated either with (pre-BAV- TAVI group) or without BAV (D-TAVI group). Implantation depth (ID) was angiographically measured at non-coronary cusp (NCC) and left coronary cusp (LCC) at: the starting point (stage-1), before (stage-2), and after (stage-3) final bioprosthesis release. Paravalvular regurgitation (PVR) was assessed after implantation, at discharge, at 1st and 6th month after TAVI and 1-year clinical follow-up were recorded. Overall, from stage-1 to stage-3, prosthesis migrated toward the left ventricle,in both cusps and groups. At NCC a forward migration was observed from stage-1 to stage-2 in both groups (p < 0.001). In the pre-BAV-TAVI group only, at NCC, an upward migration decreased the ID from stage-2 to stage-3 (p = 0.022). PVR >=grade 2, immediately after expansion was more frequently observed in pre-BAV-TAVI group (37,1% vs 10,1%, respectively; p<0,001). However, PVR was similar at discharge, 1st and 6th month after TAVI. Clinical parameters were comparable between the two groups. In pre-BAV-TAVI group left bundle branch block (LBBB) was more frequently observed vs D-TAVI group (26% vs 13%, p=0,018), but the frequency of permanent pacemaker implantation after TAVI did not differ between the two groups. In addition, BAV didn’ t increase the risk of stroke or death from any cause over time during the first year of follow-up. Finally, it was observed that patients with left ventricular ejection fraction (LVEF)< 50% at discharged appear to have 15% lower survival probability during the first year of follow-up after TAVI. The use of BAV prior to TAVI may have an impact on device final position, PVL and LBBB, but not on short- and long-term clinical outcome. Future studies are needed to investigate the safety and outcomes of direct TAVI and to identify which patients must safely undergo pre-BAV TAVI approach.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2021
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Lavda, Maria
- Λάβδα, Μαρία
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/49333